Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 10/100mg | ||||
360 pill | 10/100mg | £187.58 | £0.52 | |
180 pill | 10/100mg | £104.21 | £0.58 | |
120 pill | 10/100mg | £78.90 | £0.66 | |
90 pill | 10/100mg | £65.50 | £0.73 | |
60 pill | 10/100mg | £49.87 | £0.83 | |
30 pill | 10/100mg | £29.77 | £1.00 | |
Dosage: 25/100mg | ||||
360 pill | 25/100mg | £219.58 | £0.61 | |
180 pill | 25/100mg | £124.30 | £0.69 | |
120 pill | 25/100mg | £94.53 | £0.79 | |
90 pill | 25/100mg | £78.15 | £0.87 | |
60 pill | 25/100mg | £60.29 | £1.00 | |
30 pill | 25/100mg | £37.21 | £1.23 | |
Dosage: 25/250mg | ||||
360 pill | 25/250mg | £254.57 | £0.71 | |
180 pill | 25/250mg | £144.40 | £0.80 | |
120 pill | 25/250mg | £113.14 | £0.95 | |
90 pill | 25/250mg | £93.78 | £1.04 | |
60 pill | 25/250mg | £69.22 | £1.15 | |
30 pill | 25/250mg | £39.44 | £1.30 |

Carbidopa / Levodopa Description
Understanding Carbidopa / Levodopa
Carbidopa / Levodopa is a combination medication primarily used to treat symptoms associated with Parkinson's disease. Parkinson's is a disorder that affects movement, causing tremors, stiffness, and difficulty with coordination. This medication works by replenishing the brain's decreasing levels of dopamine, a chemical crucial for motor control and coordination. By doing so, it helps improve overall mobility and reduces the severity of symptoms. The combination of these two drugs is designed to enhance the effectiveness of Levodopa while minimizing some of its side effects.
How does Carbidopa / Levodopa work?
Levodopa is a precursor to dopamine, meaning it is converted into dopamine once it crosses the blood-brain barrier. Parkinson's disease patients experience a decline in dopamine levels, which leads to movement problems. Carbidopa works by inhibiting an enzyme called DOPA decarboxylase in the periphery, which prevents Levodopa from converting to dopamine outside the brain. This allows more Levodopa to reach the brain where it is needed the most. Additionally, by preventing peripheral conversion, Carbidopa reduces certain side effects like nausea and vomiting often associated with Levodopa therapy.
Potential Benefits of Carbidopa / Levodopa
This medication is highly effective in alleviating many motor symptoms of Parkinson's disease. Patients often experience improvements in tremors, rigidity, and bradykinesia (slowness of movement). Many users report better daily functioning and increased independence. The combination therapy is preferred over Levodopa alone because it allows for lower doses of Levodopa to be used, which can help reduce adverse effects such as dyskinesias or involuntary movements over long-term treatment.
Possible Side Effects and Precautions
While Carbidopa / Levodopa is generally well-tolerated, it can cause some side effects. Common issues include nausea, dizziness, lightheadedness, and dry mouth. As treatment progresses, some patients may develop involuntary movements, known as dyskinesias. Other potential side effects include hallucinations, confusion, or mood changes, particularly in older adults or those with additional health conditions. It's important to monitor for these symptoms and communicate regularly with a healthcare provider. Patients should avoid sudden changes in posture to prevent dizziness and be cautious when operating machinery or driving. Long-term use may require dosage adjustments to maintain efficacy and minimize side effects.
Usage and Administration Tips
Carbidopa / Levodopa is typically taken orally, with or without food. However, taking it with food may help reduce nausea, though high-protein meals can interfere with its absorption. Patients should follow their healthcare provider’s instructions carefully regarding dosing schedules. Consistency is vital, as irregular intake can lead to fluctuations in symptom control. It's essential to attend all follow-up appointments to monitor the medication's effectiveness and any side effects. Patients should never adjust the dosage without consulting their doctor, as improper use can diminish benefits or increase risks.
Conclusion
Overall, Carbidopa / Levodopa remains a cornerstone in Parkinson's disease management. Its ability to effectively alleviate symptoms and improve quality of life makes it a valuable treatment option. Nonetheless, like any medication, it requires careful monitoring to manage potential side effects and ensure optimal benefits. Patients are encouraged to maintain open communication with their healthcare team to tailor the therapy to their individual needs. Proper understanding and adherence can significantly enhance the therapeutic outcomes of this combination medication.